| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 81 | 2022 | 5063 | 7.820 |
Why?
|
| Migraine Disorders | 48 | 2023 | 1694 | 7.610 |
Why?
|
| Analgesia | 15 | 2023 | 459 | 4.710 |
Why?
|
| Brain | 94 | 2024 | 26950 | 4.270 |
Why?
|
| Complex Regional Pain Syndromes | 11 | 2020 | 121 | 3.670 |
Why?
|
| Nerve Net | 24 | 2020 | 2264 | 3.270 |
Why?
|
| Somatosensory Cortex | 14 | 2019 | 511 | 3.100 |
Why?
|
| Neuralgia | 15 | 2022 | 600 | 3.090 |
Why?
|
| Pain Measurement | 44 | 2024 | 3523 | 3.020 |
Why?
|
| Brain Mapping | 54 | 2022 | 6571 | 2.880 |
Why?
|
| Magnetic Resonance Imaging | 101 | 2022 | 36271 | 2.430 |
Why?
|
| Reward | 11 | 2019 | 965 | 2.290 |
Why?
|
| Hot Temperature | 28 | 2017 | 1434 | 2.240 |
Why?
|
| Analgesics | 17 | 2021 | 1064 | 2.220 |
Why?
|
| Neural Pathways | 26 | 2021 | 3040 | 2.180 |
Why?
|
| Hyperalgesia | 10 | 2023 | 530 | 1.890 |
Why?
|
| Pain Threshold | 12 | 2021 | 603 | 1.620 |
Why?
|
| Trigeminal Nerve | 10 | 2014 | 248 | 1.590 |
Why?
|
| Pain Perception | 4 | 2020 | 196 | 1.440 |
Why?
|
| Nociceptors | 8 | 2015 | 457 | 1.410 |
Why?
|
| Pain, Intractable | 3 | 2023 | 132 | 1.340 |
Why?
|
| Post-Traumatic Headache | 3 | 2021 | 65 | 1.270 |
Why?
|
| Enkephalins | 12 | 1999 | 139 | 1.250 |
Why?
|
| Eye Pain | 5 | 2021 | 46 | 1.240 |
Why?
|
| Habenula | 3 | 2013 | 37 | 1.230 |
Why?
|
| Cerebral Cortex | 19 | 2017 | 5756 | 1.220 |
Why?
|
| Basal Ganglia | 5 | 2015 | 553 | 1.180 |
Why?
|
| Sumatriptan | 2 | 2019 | 66 | 1.180 |
Why?
|
| Reflex Sympathetic Dystrophy | 2 | 2019 | 58 | 1.120 |
Why?
|
| Brain Stem | 9 | 2022 | 857 | 1.080 |
Why?
|
| Photophobia | 7 | 2019 | 71 | 1.050 |
Why?
|
| Physical Stimulation | 17 | 2017 | 518 | 1.040 |
Why?
|
| Irritable Bowel Syndrome | 4 | 2019 | 453 | 1.030 |
Why?
|
| Central Nervous System | 7 | 2010 | 1332 | 1.010 |
Why?
|
| Spectroscopy, Near-Infrared | 7 | 2021 | 738 | 0.990 |
Why?
|
| Amygdala | 8 | 2022 | 1351 | 0.980 |
Why?
|
| Hypothalamus | 13 | 2017 | 998 | 0.960 |
Why?
|
| Stress, Psychological | 10 | 2024 | 4456 | 0.940 |
Why?
|
| Spinal Cord | 6 | 2020 | 1815 | 0.940 |
Why?
|
| Protein Precursors | 12 | 1999 | 1133 | 0.930 |
Why?
|
| Humans | 234 | 2024 | 757650 | 0.930 |
Why?
|
| Phantom Limb | 2 | 2023 | 96 | 0.920 |
Why?
|
| Stress, Physiological | 8 | 2024 | 1398 | 0.890 |
Why?
|
| Purine Nucleosides | 4 | 2004 | 30 | 0.850 |
Why?
|
| Gyrus Cinguli | 5 | 2021 | 1115 | 0.850 |
Why?
|
| Cerebellum | 7 | 2019 | 1497 | 0.820 |
Why?
|
| Cornea | 7 | 2021 | 1326 | 0.820 |
Why?
|
| Solitary Nucleus | 1 | 2022 | 54 | 0.800 |
Why?
|
| Behavior, Addictive | 4 | 2016 | 462 | 0.800 |
Why?
|
| Efferent Pathways | 3 | 2020 | 165 | 0.800 |
Why?
|
| Placebo Effect | 2 | 2017 | 518 | 0.790 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2024 | 2387 | 0.790 |
Why?
|
| Thalamus | 9 | 2021 | 1040 | 0.780 |
Why?
|
| Wakefulness | 4 | 2021 | 1256 | 0.770 |
Why?
|
| Dry Eye Syndromes | 3 | 2021 | 385 | 0.770 |
Why?
|
| Awareness | 2 | 2018 | 644 | 0.770 |
Why?
|
| Allostasis | 2 | 2012 | 72 | 0.770 |
Why?
|
| Nucleus Accumbens | 4 | 2014 | 365 | 0.760 |
Why?
|
| Oxyhemoglobins | 1 | 2022 | 212 | 0.750 |
Why?
|
| Buprenorphine | 5 | 2013 | 654 | 0.750 |
Why?
|
| Analgesics, Opioid | 13 | 2022 | 3762 | 0.740 |
Why?
|
| Trigeminal Ganglion | 4 | 2009 | 190 | 0.740 |
Why?
|
| Central Nervous System Diseases | 4 | 2014 | 519 | 0.730 |
Why?
|
| Image Processing, Computer-Assisted | 25 | 2021 | 8945 | 0.730 |
Why?
|
| Placebos | 6 | 2017 | 1661 | 0.720 |
Why?
|
| Autonomic Nervous System | 3 | 2022 | 697 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 25 | 2020 | 8145 | 0.710 |
Why?
|
| Opioid-Related Disorders | 6 | 2022 | 2141 | 0.700 |
Why?
|
| Male | 128 | 2024 | 358227 | 0.690 |
Why?
|
| Receptors, Opioid | 2 | 2017 | 145 | 0.690 |
Why?
|
| Corneal Diseases | 4 | 2016 | 536 | 0.680 |
Why?
|
| Central Nervous System Agents | 2 | 2013 | 75 | 0.680 |
Why?
|
| Diagnostic Imaging | 7 | 2014 | 3524 | 0.670 |
Why?
|
| Anesthesia, General | 3 | 2022 | 1165 | 0.670 |
Why?
|
| Catastrophization | 6 | 2024 | 347 | 0.670 |
Why?
|
| Trigeminal Neuralgia | 3 | 2010 | 106 | 0.670 |
Why?
|
| Naproxen | 1 | 2019 | 100 | 0.650 |
Why?
|
| Peripheral Nerves | 2 | 2021 | 475 | 0.650 |
Why?
|
| Neuronal Plasticity | 8 | 2018 | 1429 | 0.640 |
Why?
|
| Models, Neurological | 6 | 2019 | 1757 | 0.640 |
Why?
|
| Ophthalmic Nerve | 2 | 2016 | 42 | 0.630 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2022 | 4562 | 0.620 |
Why?
|
| Sex Characteristics | 6 | 2019 | 2621 | 0.620 |
Why?
|
| Hallucinogens | 1 | 2021 | 195 | 0.610 |
Why?
|
| Thermosensing | 3 | 2020 | 55 | 0.610 |
Why?
|
| Neurobiology | 2 | 2018 | 137 | 0.600 |
Why?
|
| Emotions | 9 | 2021 | 2733 | 0.600 |
Why?
|
| Animals | 78 | 2023 | 167777 | 0.600 |
Why?
|
| Rest | 7 | 2019 | 914 | 0.590 |
Why?
|
| Brain Concussion | 4 | 2021 | 1397 | 0.580 |
Why?
|
| Gambling | 2 | 2012 | 258 | 0.580 |
Why?
|
| Cerebrum | 1 | 2018 | 132 | 0.570 |
Why?
|
| Pelvic Pain | 1 | 2019 | 294 | 0.570 |
Why?
|
| Prefrontal Cortex | 5 | 2019 | 2209 | 0.570 |
Why?
|
| Drug Design | 3 | 2011 | 1049 | 0.560 |
Why?
|
| Cold Temperature | 8 | 2013 | 780 | 0.560 |
Why?
|
| Trigeminal Nerve Diseases | 2 | 2008 | 49 | 0.560 |
Why?
|
| Avoidance Learning | 1 | 2018 | 248 | 0.560 |
Why?
|
| Ketamine | 2 | 2015 | 516 | 0.550 |
Why?
|
| Pulvinar | 2 | 2019 | 21 | 0.550 |
Why?
|
| Adult | 74 | 2024 | 219747 | 0.550 |
Why?
|
| Drug Discovery | 3 | 2014 | 1044 | 0.530 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 6 | 1999 | 114 | 0.530 |
Why?
|
| Consciousness | 3 | 2018 | 601 | 0.530 |
Why?
|
| Blood-Brain Barrier | 5 | 2020 | 1018 | 0.530 |
Why?
|
| Unconsciousness | 1 | 2018 | 250 | 0.520 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2015 | 42 | 0.520 |
Why?
|
| Touch | 6 | 2010 | 312 | 0.510 |
Why?
|
| Female | 87 | 2024 | 389985 | 0.510 |
Why?
|
| Touch Perception | 1 | 2017 | 106 | 0.510 |
Why?
|
| Cortical Spreading Depression | 2 | 2018 | 288 | 0.510 |
Why?
|
| Endometriosis | 2 | 2022 | 860 | 0.500 |
Why?
|
| Glutamine | 2 | 2016 | 575 | 0.490 |
Why?
|
| Clinical Trials as Topic | 8 | 2016 | 7982 | 0.490 |
Why?
|
| Peripheral Nervous System Diseases | 5 | 2019 | 709 | 0.490 |
Why?
|
| Narcotics | 3 | 2006 | 336 | 0.490 |
Why?
|
| Adolescent | 37 | 2024 | 87832 | 0.490 |
Why?
|
| Afferent Pathways | 4 | 2012 | 298 | 0.480 |
Why?
|
| Light | 7 | 2022 | 1345 | 0.480 |
Why?
|
| Neuropharmacology | 2 | 2011 | 20 | 0.480 |
Why?
|
| Anatomy, Artistic | 1 | 2014 | 51 | 0.470 |
Why?
|
| Pain, Postoperative | 3 | 2019 | 1715 | 0.470 |
Why?
|
| Hemodynamics | 4 | 2021 | 4156 | 0.470 |
Why?
|
| Drug Resistance | 2 | 2018 | 1593 | 0.460 |
Why?
|
| Tibial Nerve | 2 | 2005 | 50 | 0.460 |
Why?
|
| Rats | 26 | 2020 | 23681 | 0.460 |
Why?
|
| Cerebrovascular Circulation | 4 | 2019 | 2724 | 0.450 |
Why?
|
| Aspartic Acid | 1 | 2016 | 576 | 0.450 |
Why?
|
| Young Adult | 29 | 2024 | 58764 | 0.440 |
Why?
|
| Anesthetics | 2 | 2017 | 522 | 0.440 |
Why?
|
| Organ Specificity | 3 | 2019 | 1955 | 0.440 |
Why?
|
| Nalbuphine | 1 | 2013 | 20 | 0.430 |
Why?
|
| Headache | 4 | 2023 | 1249 | 0.420 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 351 | 0.420 |
Why?
|
| Sciatic Neuropathy | 2 | 2005 | 75 | 0.420 |
Why?
|
| Frontal Lobe | 3 | 2016 | 1419 | 0.410 |
Why?
|
| Psychophysics | 6 | 2019 | 289 | 0.410 |
Why?
|
| Visual Pathways | 3 | 2019 | 534 | 0.410 |
Why?
|
| Hypesthesia | 2 | 2019 | 107 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2014 | 1335 | 0.400 |
Why?
|
| Erythromelalgia | 1 | 2012 | 15 | 0.400 |
Why?
|
| Yohimbine | 1 | 2012 | 62 | 0.400 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 2629 | 0.400 |
Why?
|
| Neurotransmitter Agents | 5 | 2019 | 663 | 0.400 |
Why?
|
| Pleasure | 1 | 2012 | 41 | 0.400 |
Why?
|
| Locus Coeruleus | 1 | 2014 | 230 | 0.400 |
Why?
|
| Cerebellar Diseases | 1 | 2014 | 219 | 0.400 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2019 | 1132 | 0.390 |
Why?
|
| Oxygen | 12 | 2015 | 4190 | 0.390 |
Why?
|
| Tomography, Optical | 2 | 2009 | 129 | 0.390 |
Why?
|
| Pons | 2 | 2012 | 239 | 0.390 |
Why?
|
| Attitude | 1 | 2016 | 776 | 0.390 |
Why?
|
| Parent-Child Relations | 1 | 2016 | 759 | 0.380 |
Why?
|
| Blepharospasm | 1 | 2011 | 29 | 0.380 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18123 | 0.380 |
Why?
|
| Periaqueductal Gray | 1 | 2011 | 110 | 0.370 |
Why?
|
| Child | 27 | 2024 | 79787 | 0.370 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2008 | 675 | 0.360 |
Why?
|
| Adaptation, Physiological | 3 | 2012 | 1294 | 0.360 |
Why?
|
| Basal Metabolism | 1 | 2011 | 161 | 0.360 |
Why?
|
| Motor Activity | 1 | 2020 | 2686 | 0.360 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1167 | 0.360 |
Why?
|
| Membrane Potentials | 1 | 2013 | 1094 | 0.350 |
Why?
|
| Guidelines as Topic | 3 | 2011 | 1384 | 0.350 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2009 | 18 | 0.340 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2009 | 23 | 0.340 |
Why?
|
| Motor Cortex | 4 | 2014 | 997 | 0.330 |
Why?
|
| Gene Expression Regulation | 13 | 1999 | 11893 | 0.330 |
Why?
|
| Pain Insensitivity, Congenital | 1 | 2009 | 8 | 0.330 |
Why?
|
| Affect | 3 | 2013 | 1480 | 0.330 |
Why?
|
| Middle Aged | 41 | 2024 | 219219 | 0.320 |
Why?
|
| Anesthetics, Dissociative | 1 | 2009 | 80 | 0.320 |
Why?
|
| Medical Records | 1 | 2014 | 1406 | 0.320 |
Why?
|
| beta-Galactosidase | 8 | 1999 | 574 | 0.320 |
Why?
|
| Comorbidity | 2 | 2022 | 10478 | 0.310 |
Why?
|
| Neurosciences | 1 | 2013 | 353 | 0.310 |
Why?
|
| Mononeuropathies | 1 | 2008 | 13 | 0.310 |
Why?
|
| Triazines | 1 | 2010 | 310 | 0.300 |
Why?
|
| Naloxone | 3 | 2013 | 369 | 0.300 |
Why?
|
| Case-Control Studies | 12 | 2019 | 22024 | 0.300 |
Why?
|
| Colonoscopy | 1 | 2016 | 1385 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 1999 | 490 | 0.300 |
Why?
|
| Mental Disorders | 3 | 2017 | 6802 | 0.300 |
Why?
|
| Optic Nerve | 1 | 2011 | 567 | 0.290 |
Why?
|
| Interleukin-1 | 3 | 2000 | 1249 | 0.290 |
Why?
|
| Comprehension | 1 | 2012 | 618 | 0.280 |
Why?
|
| Aging | 2 | 2017 | 8650 | 0.280 |
Why?
|
| Tics | 1 | 2007 | 74 | 0.280 |
Why?
|
| Drug Evaluation | 1 | 2008 | 642 | 0.280 |
Why?
|
| Cluster Headache | 1 | 2007 | 54 | 0.270 |
Why?
|
| Cross-Over Studies | 5 | 2013 | 2048 | 0.270 |
Why?
|
| Parents | 3 | 2018 | 3548 | 0.270 |
Why?
|
| Trigeminal Nuclei | 1 | 2006 | 39 | 0.270 |
Why?
|
| Temporal Lobe | 4 | 2019 | 1688 | 0.260 |
Why?
|
| Brachial Plexus | 1 | 2008 | 166 | 0.260 |
Why?
|
| Behavior | 3 | 2017 | 540 | 0.260 |
Why?
|
| Neurons, Afferent | 3 | 2010 | 498 | 0.260 |
Why?
|
| Capsaicin | 1 | 2007 | 231 | 0.260 |
Why?
|
| Social Behavior | 1 | 2012 | 1132 | 0.260 |
Why?
|
| Face | 3 | 2009 | 1017 | 0.260 |
Why?
|
| Neurons | 10 | 2017 | 9419 | 0.260 |
Why?
|
| Reaction Time | 3 | 2012 | 2076 | 0.260 |
Why?
|
| Brain Chemistry | 1 | 2009 | 959 | 0.250 |
Why?
|
| Motivation | 2 | 2016 | 1996 | 0.250 |
Why?
|
| Putamen | 2 | 2020 | 291 | 0.250 |
Why?
|
| Societies, Medical | 1 | 2017 | 3887 | 0.250 |
Why?
|
| Chronic Disease | 10 | 2021 | 9265 | 0.250 |
Why?
|
| Capillary Permeability | 2 | 2019 | 769 | 0.250 |
Why?
|
| Injections, Intravenous | 4 | 2017 | 1379 | 0.250 |
Why?
|
| Nerve Fibers | 2 | 2021 | 708 | 0.240 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2024 | 2782 | 0.240 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1647 | 0.240 |
Why?
|
| Pediatrics | 2 | 2023 | 3586 | 0.240 |
Why?
|
| Anxiety | 5 | 2024 | 4533 | 0.230 |
Why?
|
| Tongue | 1 | 2007 | 403 | 0.230 |
Why?
|
| Empathy | 1 | 2009 | 472 | 0.230 |
Why?
|
| Morphine | 3 | 2006 | 653 | 0.230 |
Why?
|
| Substance-Related Disorders | 3 | 2016 | 4403 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 2 | 2017 | 166 | 0.230 |
Why?
|
| Cyclohexanecarboxylic Acids | 4 | 2014 | 140 | 0.230 |
Why?
|
| Movement | 2 | 2007 | 1474 | 0.220 |
Why?
|
| Medulla Oblongata | 3 | 2022 | 248 | 0.220 |
Why?
|
| Spin Labels | 2 | 2017 | 336 | 0.220 |
Why?
|
| Dopamine | 3 | 2023 | 1599 | 0.220 |
Why?
|
| Lipopolysaccharides | 3 | 2000 | 2204 | 0.220 |
Why?
|
| Amines | 4 | 2014 | 281 | 0.210 |
Why?
|
| Naltrexone | 3 | 2013 | 317 | 0.210 |
Why?
|
| Endocannabinoids | 1 | 2023 | 111 | 0.210 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3975 | 0.210 |
Why?
|
| Dura Mater | 2 | 2018 | 290 | 0.210 |
Why?
|
| Polyneuropathies | 1 | 2004 | 137 | 0.210 |
Why?
|
| Peroneal Nerve | 1 | 2002 | 76 | 0.210 |
Why?
|
| Hand | 2 | 2008 | 902 | 0.200 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1503 | 0.200 |
Why?
|
| Technology, Pharmaceutical | 1 | 2002 | 84 | 0.200 |
Why?
|
| Internet | 1 | 2014 | 3081 | 0.200 |
Why?
|
| Neurites | 1 | 2024 | 390 | 0.200 |
Why?
|
| Drug Delivery Systems | 3 | 2020 | 2211 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 1088 | 0.200 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 956 | 0.190 |
Why?
|
| Infusions, Intravenous | 3 | 2013 | 2212 | 0.190 |
Why?
|
| Analysis of Variance | 5 | 2016 | 6231 | 0.190 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2015 | 246 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2008 | 2211 | 0.190 |
Why?
|
| Cohort Studies | 9 | 2023 | 41198 | 0.190 |
Why?
|
| Sodium Chloride | 2 | 2017 | 588 | 0.180 |
Why?
|
| Ganglia, Spinal | 1 | 2023 | 523 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 10750 | 0.180 |
Why?
|
| Pituitary-Adrenal System | 1 | 2024 | 552 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2019 | 952 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1882 | 0.180 |
Why?
|
| Drug Monitoring | 2 | 2010 | 960 | 0.170 |
Why?
|
| Infusions, Intraventricular | 1 | 2019 | 32 | 0.170 |
Why?
|
| Pilot Projects | 5 | 2024 | 8551 | 0.170 |
Why?
|
| Headache Disorders | 1 | 2022 | 148 | 0.170 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2022 | 196 | 0.170 |
Why?
|
| Foot | 1 | 2004 | 573 | 0.170 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2024 | 700 | 0.170 |
Why?
|
| Motor Skills Disorders | 1 | 2020 | 89 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 2248 | 0.170 |
Why?
|
| Hippocampus | 1 | 2012 | 3739 | 0.170 |
Why?
|
| Temperature | 2 | 2021 | 2219 | 0.170 |
Why?
|
| Age Factors | 4 | 2019 | 18328 | 0.170 |
Why?
|
| Low Back Pain | 1 | 2008 | 979 | 0.160 |
Why?
|
| Anesthesia | 1 | 2010 | 1581 | 0.160 |
Why?
|
| Microbubbles | 1 | 2020 | 128 | 0.160 |
Why?
|
| Sensory Thresholds | 2 | 2019 | 377 | 0.160 |
Why?
|
| Sprains and Strains | 1 | 2019 | 75 | 0.160 |
Why?
|
| Illness Behavior | 1 | 2018 | 23 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2008 | 1541 | 0.160 |
Why?
|
| Double-Blind Method | 6 | 2023 | 12260 | 0.160 |
Why?
|
| Benzodiazepines | 4 | 2013 | 1130 | 0.160 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1999 | 147 | 0.160 |
Why?
|
| Buttocks | 1 | 1998 | 111 | 0.160 |
Why?
|
| Psychiatry | 1 | 2011 | 1690 | 0.150 |
Why?
|
| Quality Control | 2 | 2011 | 825 | 0.150 |
Why?
|
| Synaptic Transmission | 3 | 2017 | 1168 | 0.150 |
Why?
|
| Discrimination Learning | 1 | 2020 | 278 | 0.150 |
Why?
|
| Electroretinography | 2 | 2019 | 517 | 0.150 |
Why?
|
| Drug Utilization Review | 1 | 1999 | 248 | 0.150 |
Why?
|
| Dark Adaptation | 1 | 2019 | 221 | 0.150 |
Why?
|
| Nitroglycerin | 1 | 2019 | 328 | 0.150 |
Why?
|
| Pia Mater | 1 | 2018 | 87 | 0.150 |
Why?
|
| Narcotic Antagonists | 4 | 2012 | 583 | 0.150 |
Why?
|
| Thalamic Nuclei | 2 | 2023 | 111 | 0.150 |
Why?
|
| Color Perception | 1 | 2018 | 212 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2863 | 0.150 |
Why?
|
| Evoked Potentials, Visual | 2 | 2019 | 415 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 4 | 1998 | 3734 | 0.140 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 238 | 0.140 |
Why?
|
| Mice, Transgenic | 10 | 2018 | 9519 | 0.140 |
Why?
|
| Melatonin | 1 | 2022 | 668 | 0.140 |
Why?
|
| Triamcinolone | 1 | 1996 | 68 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 791 | 0.140 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2016 | 314 | 0.130 |
Why?
|
| Trigeminal Nucleus, Spinal | 2 | 2008 | 21 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2023 | 64242 | 0.130 |
Why?
|
| Basal Ganglia Diseases | 1 | 2016 | 145 | 0.130 |
Why?
|
| Positron-Emission Tomography | 4 | 2017 | 6457 | 0.130 |
Why?
|
| Biomedical Research | 2 | 2013 | 3416 | 0.130 |
Why?
|
| Drug-Seeking Behavior | 1 | 2016 | 46 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3338 | 0.130 |
Why?
|
| Facial Pain | 1 | 2016 | 120 | 0.130 |
Why?
|
| Depression | 4 | 2021 | 8052 | 0.130 |
Why?
|
| Parietal Lobe | 3 | 2014 | 849 | 0.120 |
Why?
|
| Ankle Injuries | 1 | 2019 | 334 | 0.120 |
Why?
|
| Drug Combinations | 2 | 2019 | 2020 | 0.120 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2016 | 180 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2022 | 881 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2016 | 361 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2020 | 4902 | 0.120 |
Why?
|
| Drug Industry | 2 | 2011 | 787 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 973 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 1998 | 944 | 0.120 |
Why?
|
| Midazolam | 1 | 2016 | 266 | 0.120 |
Why?
|
| Neuropeptides | 2 | 2017 | 943 | 0.110 |
Why?
|
| Neurosecretory Systems | 1 | 1995 | 221 | 0.110 |
Why?
|
| Biological Clocks | 1 | 2016 | 316 | 0.110 |
Why?
|
| Lidocaine | 1 | 1997 | 537 | 0.110 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 25931 | 0.110 |
Why?
|
| Genes, fos | 1 | 1994 | 174 | 0.110 |
Why?
|
| Pruritus | 1 | 1997 | 377 | 0.110 |
Why?
|
| Parahippocampal Gyrus | 1 | 2014 | 115 | 0.110 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 662 | 0.110 |
Why?
|
| Electromyography | 1 | 1998 | 1388 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2021 | 2675 | 0.110 |
Why?
|
| Reproducibility of Results | 9 | 2015 | 20039 | 0.110 |
Why?
|
| Tears | 1 | 2015 | 251 | 0.110 |
Why?
|
| Photic Stimulation | 3 | 2019 | 1967 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2017 | 548 | 0.100 |
Why?
|
| Genitalia, Male | 1 | 1992 | 87 | 0.100 |
Why?
|
| Physicians | 2 | 2023 | 4578 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1788 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2015 | 915 | 0.100 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2012 | 18 | 0.100 |
Why?
|
| Supraoptic Nucleus | 3 | 1999 | 28 | 0.100 |
Why?
|
| Genes, Synthetic | 1 | 1992 | 88 | 0.100 |
Why?
|
| Brain Waves | 1 | 2016 | 401 | 0.100 |
Why?
|
| Administration, Sublingual | 1 | 2011 | 58 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 1999 | 2426 | 0.100 |
Why?
|
| Nerve Block | 1 | 1998 | 687 | 0.100 |
Why?
|
| Normal Distribution | 2 | 2010 | 272 | 0.100 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 208 | 0.100 |
Why?
|
| Appetite Depressants | 1 | 2012 | 108 | 0.100 |
Why?
|
| Sensation | 3 | 2019 | 331 | 0.100 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2013 | 326 | 0.100 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2012 | 132 | 0.100 |
Why?
|
| Genitalia, Female | 1 | 1992 | 147 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2016 | 529 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2017 | 2608 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 1184 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2019 | 1089 | 0.090 |
Why?
|
| Disease Progression | 3 | 2024 | 13464 | 0.090 |
Why?
|
| Retina | 2 | 2019 | 2637 | 0.090 |
Why?
|
| Homeostasis | 1 | 2022 | 3302 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 3 | 1998 | 114 | 0.090 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2013 | 628 | 0.090 |
Why?
|
| Forelimb | 1 | 2010 | 115 | 0.090 |
Why?
|
| Bipolar Disorder | 3 | 2011 | 5083 | 0.090 |
Why?
|
| Time Factors | 6 | 2013 | 39815 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1177 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 925 | 0.090 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2000 | 2859 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 8543 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2248 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2000 | 2685 | 0.090 |
Why?
|
| Phenotype | 3 | 2021 | 16533 | 0.090 |
Why?
|
| Caudate Nucleus | 1 | 2011 | 389 | 0.090 |
Why?
|
| Sex Factors | 2 | 2014 | 10497 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3208 | 0.090 |
Why?
|
| Models, Biological | 3 | 2014 | 9460 | 0.090 |
Why?
|
| Species Specificity | 2 | 2013 | 2416 | 0.080 |
Why?
|
| Abdominal Pain | 1 | 2016 | 1064 | 0.080 |
Why?
|
| Anticipation, Psychological | 1 | 2010 | 85 | 0.080 |
Why?
|
| Aged | 12 | 2020 | 167889 | 0.080 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2357 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2013 | 850 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2010 | 304 | 0.080 |
Why?
|
| Self Report | 2 | 2020 | 3709 | 0.080 |
Why?
|
| Disabled Persons | 2 | 2017 | 1224 | 0.080 |
Why?
|
| Psychotherapy | 2 | 2017 | 1640 | 0.080 |
Why?
|
| Channelopathies | 1 | 2009 | 30 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1968 | 0.080 |
Why?
|
| Circadian Rhythm | 3 | 2022 | 2567 | 0.080 |
Why?
|
| Muscimol | 2 | 1999 | 70 | 0.080 |
Why?
|
| Sleep | 4 | 2023 | 4745 | 0.080 |
Why?
|
| Models, Genetic | 2 | 1996 | 3441 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1976 | 0.080 |
Why?
|
| Mice | 14 | 2023 | 81107 | 0.080 |
Why?
|
| Linear Models | 3 | 2010 | 5857 | 0.080 |
Why?
|
| Antipsychotic Agents | 3 | 2013 | 3060 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15532 | 0.080 |
Why?
|
| Weight Gain | 2 | 2012 | 2345 | 0.080 |
Why?
|
| Action Potentials | 2 | 2010 | 1816 | 0.080 |
Why?
|
| Reference Values | 2 | 2008 | 4918 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2012 | 657 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1176 | 0.080 |
Why?
|
| Cerebellar Nuclei | 1 | 2008 | 51 | 0.070 |
Why?
|
| Dreams | 1 | 2009 | 146 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2018 | 2970 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1373 | 0.070 |
Why?
|
| Epilepsy | 1 | 2023 | 3270 | 0.070 |
Why?
|
| Dipeptides | 1 | 2009 | 386 | 0.070 |
Why?
|
| Estrogens | 1 | 2014 | 1521 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1996 | 2145 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 2022 | 518 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2495 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2723 | 0.070 |
Why?
|
| Military Personnel | 1 | 2016 | 1240 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9163 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 2 | 2012 | 412 | 0.070 |
Why?
|
| Perception | 1 | 2013 | 1194 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 7799 | 0.070 |
Why?
|
| Limbic System | 1 | 2009 | 419 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15782 | 0.070 |
Why?
|
| Models, Economic | 1 | 2010 | 715 | 0.070 |
Why?
|
| Research | 1 | 2014 | 1975 | 0.060 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 3239 | 0.060 |
Why?
|
| Inflammation | 3 | 2012 | 10718 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2013 | 1188 | 0.060 |
Why?
|
| Imipramine | 1 | 2005 | 98 | 0.060 |
Why?
|
| Sensory Receptor Cells | 1 | 2010 | 509 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2010 | 1806 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7401 | 0.060 |
Why?
|
| Individuality | 1 | 2007 | 300 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2019 | 1732 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2023 | 54108 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 1999 | 1455 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2000 | 9574 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2007 | 696 | 0.060 |
Why?
|
| Cognition | 2 | 2015 | 6955 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7590 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3667 | 0.060 |
Why?
|
| Injections | 1 | 2008 | 830 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2127 | 0.060 |
Why?
|
| Eating | 2 | 2014 | 1537 | 0.060 |
Why?
|
| Injections, Intramuscular | 2 | 2012 | 553 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 20499 | 0.060 |
Why?
|
| Receptors, GABA-A | 2 | 1986 | 621 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2017 | 42044 | 0.060 |
Why?
|
| Phosphorylation | 4 | 1999 | 8298 | 0.050 |
Why?
|
| Raynaud Disease | 1 | 2004 | 79 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2013 | 1666 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2475 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2005 | 431 | 0.050 |
Why?
|
| Skin | 1 | 2017 | 4464 | 0.050 |
Why?
|
| Macrophages | 1 | 2018 | 5736 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2741 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2004 | 439 | 0.050 |
Why?
|
| Fear | 2 | 2015 | 1463 | 0.050 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2023 | 137 | 0.050 |
Why?
|
| Life Style | 1 | 2014 | 3886 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2019 | 79982 | 0.050 |
Why?
|
| Posterior Horn Cells | 1 | 2002 | 90 | 0.050 |
Why?
|
| Suicide | 1 | 2013 | 1593 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2014 | 2045 | 0.050 |
Why?
|
| Pyrogens | 2 | 1978 | 17 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2013 | 3299 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 2687 | 0.050 |
Why?
|
| Schizophrenia | 2 | 2013 | 6913 | 0.050 |
Why?
|
| Age of Onset | 1 | 2008 | 3296 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1994 | 585 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 7024 | 0.050 |
Why?
|
| Baroreflex | 1 | 2022 | 148 | 0.050 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2002 | 368 | 0.050 |
Why?
|
| Serotonin | 2 | 2014 | 1040 | 0.050 |
Why?
|
| Forecasting | 1 | 2010 | 2919 | 0.050 |
Why?
|
| Solubility | 1 | 2002 | 1087 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2000 | 149 | 0.050 |
Why?
|
| Electronics, Medical | 1 | 2000 | 72 | 0.050 |
Why?
|
| Ethics | 1 | 2000 | 93 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2002 | 305 | 0.040 |
Why?
|
| Thumb | 1 | 2002 | 232 | 0.040 |
Why?
|
| Spinal Nerves | 1 | 2000 | 91 | 0.040 |
Why?
|
| Toxicology | 1 | 2000 | 102 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 1999 | 18941 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 6012 | 0.040 |
Why?
|
| United States | 4 | 2020 | 71907 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1999 | 100 | 0.040 |
Why?
|
| Rod Opsins | 1 | 2019 | 108 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 1994 | 1900 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 221 | 0.040 |
Why?
|
| Phosphoserine | 1 | 1999 | 203 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 1999 | 150 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1999 | 225 | 0.040 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 1999 | 88 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2000 | 333 | 0.040 |
Why?
|
| Sacroiliac Joint | 1 | 1998 | 57 | 0.040 |
Why?
|
| Aminooxyacetic Acid | 1 | 1998 | 7 | 0.040 |
Why?
|
| Hindlimb | 1 | 2000 | 508 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2000 | 384 | 0.040 |
Why?
|
| Urinalysis | 1 | 2000 | 368 | 0.040 |
Why?
|
| Iopamidol | 1 | 1998 | 186 | 0.040 |
Why?
|
| Logistic Models | 2 | 2017 | 13222 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3909 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 5481 | 0.040 |
Why?
|
| Sciatica | 1 | 1998 | 97 | 0.040 |
Why?
|
| Work Schedule Tolerance | 1 | 2022 | 551 | 0.040 |
Why?
|
| GABA-A Receptor Agonists | 1 | 1998 | 86 | 0.040 |
Why?
|
| Algorithms | 4 | 2011 | 13952 | 0.040 |
Why?
|
| Skin Temperature | 2 | 1993 | 96 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2000 | 428 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 3171 | 0.040 |
Why?
|
| Education | 1 | 2020 | 533 | 0.040 |
Why?
|
| Cryptosporidiosis | 1 | 1997 | 52 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2003 | 1474 | 0.040 |
Why?
|
| Hand Strength | 1 | 2020 | 452 | 0.040 |
Why?
|
| Hair | 1 | 2000 | 497 | 0.030 |
Why?
|
| Celiac Plexus | 1 | 1996 | 28 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3560 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17767 | 0.030 |
Why?
|
| Vibration | 1 | 2019 | 328 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2000 | 1568 | 0.030 |
Why?
|
| Sacrum | 1 | 1998 | 276 | 0.030 |
Why?
|
| Radiography | 1 | 2008 | 6957 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1999 | 535 | 0.030 |
Why?
|
| Occupational Therapy | 1 | 2017 | 139 | 0.030 |
Why?
|
| Motor Neurons | 2 | 1998 | 864 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 243 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2269 | 0.030 |
Why?
|
| Color | 1 | 2017 | 298 | 0.030 |
Why?
|
| Water | 1 | 2002 | 1402 | 0.030 |
Why?
|
| Saliva | 1 | 2000 | 820 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2847 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2000 | 869 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2083 | 0.030 |
Why?
|
| Quality of Life | 2 | 2017 | 13265 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2021 | 618 | 0.030 |
Why?
|
| Software | 1 | 2009 | 4416 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 794 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 2008 | 0.030 |
Why?
|
| Needles | 1 | 1998 | 450 | 0.030 |
Why?
|
| Disabled Children | 1 | 2018 | 251 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 1977 | 286 | 0.030 |
Why?
|
| Risk Factors | 3 | 2019 | 73716 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2000 | 747 | 0.030 |
Why?
|
| Body Temperature | 1 | 1978 | 777 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2013 | 23342 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2006 | 2714 | 0.030 |
Why?
|
| Acetabulum | 1 | 1998 | 541 | 0.030 |
Why?
|
| Radiology, Interventional | 1 | 1998 | 474 | 0.030 |
Why?
|
| Methadone | 1 | 1997 | 320 | 0.030 |
Why?
|
| Microdialysis | 1 | 2014 | 160 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 2004 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 1994 | 137 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 806 | 0.030 |
Why?
|
| Hypothalamic Hormones | 1 | 2014 | 145 | 0.030 |
Why?
|
| Pituitary Hormones | 1 | 2014 | 182 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 1999 | 12761 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 285 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 389 | 0.030 |
Why?
|
| Incidence | 2 | 2023 | 21217 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2006 | 3726 | 0.030 |
Why?
|
| Vasopressins | 1 | 2014 | 351 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 4744 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2016 | 459 | 0.030 |
Why?
|
| Hypothalamus, Middle | 2 | 1997 | 15 | 0.030 |
Why?
|
| Histamine | 1 | 2014 | 497 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4845 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2022 | 1469 | 0.030 |
Why?
|
| Blood Volume | 1 | 1994 | 548 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2010 | 1489 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 289 | 0.030 |
Why?
|
| Femur | 1 | 1998 | 1302 | 0.030 |
Why?
|
| Genes, jun | 1 | 1992 | 68 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2013 | 522 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2012 | 84 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2017 | 869 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2014 | 897 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20999 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 1998 | 1112 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29493 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6371 | 0.020 |
Why?
|
| Mood Disorders | 1 | 2017 | 1124 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1994 | 582 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1997 | 707 | 0.020 |
Why?
|
| Heart Rate | 1 | 2022 | 4166 | 0.020 |
Why?
|
| Oxytocin | 1 | 2014 | 401 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4169 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 788 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1999 | 4113 | 0.020 |
Why?
|
| Estradiol | 1 | 1997 | 1933 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1994 | 2263 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2015 | 2922 | 0.020 |
Why?
|
| Pancreatitis | 1 | 1996 | 1096 | 0.020 |
Why?
|
| Fever | 1 | 1977 | 1617 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 3864 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8502 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6525 | 0.020 |
Why?
|
| Euphoria | 1 | 2008 | 65 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1746 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 961 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1844 | 0.020 |
Why?
|
| Axons | 1 | 1996 | 1674 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2015 | 1825 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2976 | 0.020 |
Why?
|
| Arteries | 1 | 2013 | 1125 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2387 | 0.020 |
Why?
|
| Protein Binding | 1 | 2000 | 9312 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58559 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1415 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 22008 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9297 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1997 | 1422 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1999 | 4215 | 0.020 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 1986 | 13 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2022 | 8452 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11065 | 0.020 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1986 | 50 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2010 | 6198 | 0.020 |
Why?
|
| Flunitrazepam | 1 | 1985 | 20 | 0.020 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 1986 | 87 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 986 | 0.020 |
Why?
|
| Peroxides | 1 | 2005 | 73 | 0.020 |
Why?
|
| Base Sequence | 2 | 1994 | 12437 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 1985 | 89 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1986 | 451 | 0.020 |
Why?
|
| Contrast Media | 1 | 1998 | 5297 | 0.020 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1986 | 139 | 0.020 |
Why?
|
| Carbamazepine | 1 | 1986 | 224 | 0.020 |
Why?
|
| Functional Laterality | 2 | 2005 | 2252 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39018 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2000 | 14354 | 0.010 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 1 | 1986 | 96 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1868 | 0.010 |
Why?
|
| Attention | 1 | 2014 | 2387 | 0.010 |
Why?
|
| Leptin | 1 | 2012 | 1591 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2870 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2090 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 17617 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1986 | 628 | 0.010 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 1983 | 13 | 0.010 |
Why?
|
| Urea | 1 | 2005 | 444 | 0.010 |
Why?
|
| Valproic Acid | 1 | 1986 | 442 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 1983 | 66 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1983 | 122 | 0.010 |
Why?
|
| Lithium | 1 | 1986 | 596 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 7584 | 0.010 |
Why?
|
| Lipids | 1 | 2013 | 3326 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14478 | 0.010 |
Why?
|
| Clozapine | 1 | 2006 | 506 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 1999 | 7366 | 0.010 |
Why?
|
| Palliative Care | 1 | 1997 | 3568 | 0.010 |
Why?
|
| Rabbits | 2 | 1978 | 4771 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2320 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2015 | 23819 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14638 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2012 | 3182 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3941 | 0.010 |
Why?
|
| Quinones | 1 | 1999 | 78 | 0.010 |
Why?
|
| Rifabutin | 1 | 1999 | 58 | 0.010 |
Why?
|
| Benzoquinones | 1 | 1999 | 198 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2696 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 3197 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1983 | 669 | 0.010 |
Why?
|
| Fenclonine | 1 | 1977 | 16 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2013 | 6549 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 1999 | 315 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1977 | 169 | 0.010 |
Why?
|
| Spinothalamic Tracts | 1 | 1996 | 8 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1999 | 5779 | 0.010 |
Why?
|
| Hydromorphone | 1 | 1997 | 70 | 0.010 |
Why?
|
| Papio | 1 | 1978 | 662 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10135 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2013 | 12870 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13603 | 0.010 |
Why?
|
| Retreatment | 1 | 1997 | 596 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2006 | 2868 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1997 | 610 | 0.010 |
Why?
|
| Thermoreceptors | 1 | 1993 | 27 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2673 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36043 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1999 | 1356 | 0.010 |
Why?
|
| Cattle | 1 | 1978 | 3845 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1835 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15209 | 0.010 |
Why?
|
| Astrocytes | 1 | 1999 | 1337 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5779 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 29720 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 1704 | 0.010 |
Why?
|
| Leukocytes | 1 | 1978 | 2025 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 3709 | 0.000 |
Why?
|
| Swine | 1 | 1978 | 5892 | 0.000 |
Why?
|
| Recurrence | 1 | 1983 | 8426 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 12950 | 0.000 |
Why?
|